Literature DB >> 22327410

The effects of schistosomiasis on HIV/AIDS infection, progression and transmission.

W Evan Secor1.   

Abstract

PURPOSE OF REVIEW: The recent findings pertaining to the public health impact of schistosomiasis on the epidemiology of HIV/AIDS are summarized. RECENT
FINDINGS: Both empiric data and mathematical models support the hypothesis that schistosome infections lead to increased susceptibility to infection with HIV-1, a more rapid progression to disease through more vigorous viral replication and immunosuppression, and a higher likelihood of transmitting the infection to others through both vertical and horizontal routes. Different species of schistosome infection vary in the magnitude of their effects on these mechanisms with Schistosoma haematobium playing a greater role for increased susceptibility and transmission because of its association with urogenital disease.
SUMMARY: Schistosomiasis appears to be a cofactor in the spread and progression of HIV/AIDS in areas wherein both diseases are endemic; increased emphasis on treatment of schistosome infections in persons at risk of HIV/AIDS should be pursued.

Entities:  

Mesh:

Year:  2012        PMID: 22327410     DOI: 10.1097/COH.0b013e328351b9e3

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  40 in total

1.  Considering treatment of male genital schistosomiasis as a tool for future HIV prevention: a systematic review.

Authors:  Chalotte Willemann Stecher; Per Kallestrup; Eyrun Floerecke Kjetland; Birgitte Vennervald; Eskild Petersen
Journal:  Int J Public Health       Date:  2015-08-23       Impact factor: 3.380

2.  Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  Vaccine       Date:  2014-01-04       Impact factor: 3.641

3.  Derivatives of biarylalkyl carboxylic acid induce pleiotropic phenotypes in adult Schistosoma mansoni in vitro.

Authors:  Ariane S Blohm; Patrick Mäder; Thomas Quack; Zhigang Lu; Steffen Hahnel; Martin Schlitzer; Christoph G Grevelding
Journal:  Parasitol Res       Date:  2016-05-26       Impact factor: 2.289

4.  Acute paraplegia caused by Schistosoma mansoni.

Authors:  Mahmood D Al-Mendalawi
Journal:  Neurosciences (Riyadh)       Date:  2014-10       Impact factor: 0.906

Review 5.  Population Structure and Dynamics of Helminthic Infection: Schistosomiasis.

Authors:  Ronald E Blanton
Journal:  Microbiol Spectr       Date:  2019-07

Review 6.  Tissue Parasites in HIV Infection.

Authors:  Eva H Clark; Jose A Serpa
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

7.  Contextualizing Schistosoma haematobium transmission in Ghana: Assessment of diagnostic techniques and individual and community water-related risk factors.

Authors:  Alexandra V Kulinkina; Karen C Kosinski; Michael N Adjei; Dickson Osabutey; Bernard O Gyamfi; Nana-Kwadwo Biritwum; Kwabena M Bosompem; Elena N Naumova
Journal:  Acta Trop       Date:  2019-03-11       Impact factor: 3.112

8.  Association of Schistosomiasis and HIV infection in Tanzania.

Authors:  Jennifer A Downs; Govert J van Dam; John M Changalucha; Paul L A M Corstjens; Robert N Peck; Claudia J de Dood; Heejung Bang; Aura Andreasen; Samuel E Kalluvya; Lisette van Lieshout; Warren D Johnson; Daniel W Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

9.  Interactions of Schistosoma and HIV in Sub-Saharan Africa: A Systematic Review.

Authors:  Briana D Furch; John R Koethe; Violet Kayamba; Douglas C Heimburger; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

10.  Tropical Parasitic Infections in Individuals Infected with HIV.

Authors:  Emily E Evans; Mark J Siedner
Journal:  Curr Trop Med Rep       Date:  2017-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.